Spherotech
Private Company
Funding information not available
Overview
Spherotech is a long-established, privately-held specialty manufacturer providing critical consumable components to the global life sciences research and diagnostic tools market. The company's business model is focused on producing and selling a wide array of standardized and custom microparticles that serve as calibration standards, assay substrates, and separation media. It generates revenue through direct sales of its catalog products and custom manufacturing services, primarily targeting academic, biotech, and diagnostic kit developers. Spherotech maintains its market position by offering specialized particle chemistries and participating actively in major industry conferences.
Technology Platform
Design, synthesis, and functionalization of precision polymer microparticles, microspheres, and nanoparticles for calibration, assay development, and separation in life sciences.
Opportunities
Risk Factors
Competitive Landscape
Spherotech competes in a specialized segment dominated by large conglomerates like Thermo Fisher Scientific, BD Biosciences, and Merck MilliporeSigma, which offer broad portfolios of particles and reagents. Its competitive advantage lies in specialization, custom manufacturing capabilities, and focus on technical support for niche applications. Smaller rivals include other specialty bead manufacturers like Polysciences, Inc. and Bangs Laboratories.